Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
34.47
-0.86 (-2.43%)
At close: Oct 23, 2026, 4:00 PM EDT
34.01
-0.46 (-1.33%)
Pre-market: Oct 26, 2026, 4:27 AM EDT
Indivior Pharmaceuticals Market Cap
Indivior Pharmaceuticals has a market cap or net worth of $4.07 billion as of October 23, 2026. It is the 4,187th most valuable company in the world and the 1,295th biggest in the United States. Its market cap has increased by 30.94% in one year.
Market Cap
4.07B
Enterprise Value
4.35B
1-Year Change
30.94%
Global Rank
Country Rank
#1,295 United States
Category
ChartMarket Cap Chart
Since June 12, 2023, Indivior Pharmaceuticals's market cap has increased from $3.14B to $4.07B, an increase of 29.57%. That is a compound annual growth rate of 8.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 4.07B | -9.19% |
| Dec 31, 2025 | 4.48B | 161.27% |
| Dec 31, 2024 | 1.71B | -18.60% |
| Dec 29, 2023 | 2.11B | -32.91% |
| Jun 12, 2023 | 3.14B | - |
View and export this data all the way back to 2023. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amneal Pharmaceuticals | 7.10B |
| Lantheus Holdings | 6.51B |
| Hims & Hers Health | 6.47B |
| Kiniksa Pharmaceuticals International, | 5.99B |
| Liquidia | 3.82B |
| Regencell Bioscience Holdings | 3.80B |
| Amylyx Pharmaceuticals | 3.41B |
| HUTCHMED (China) | 2.53B |